A phase I pharmacokinetic (PK) study of TSU-68 plus S-1 and oxaliplatin (SOX) in patients with metastatic colorectal cancer (mCRC) treated with prior chemotherapy

被引：0
|
作者：
Shin, Sang Joon
Ahn, Joong Bae
Jeung, Hei-Cheul
Rha, Sun Young
Roh, Jae Kyung
Ahn, Jung Ryun
Kim, Chan
Chung, Hyun Cheol
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B8
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy
    Shin, Sang Joon
    Jung, Minkyu
    Jeung, Hei-Cheul
    Kim, Hye Ryun
    Rha, Sun Young
    Roh, Jae Kyung
    Chung, Hyun Cheol
    Ahn, Joong Bae
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1501 - 1510
  • [2] A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy
    Sang Joon Shin
    Minkyu Jung
    Hei-Cheul Jeung
    Hye Ryun Kim
    Sun Young Rha
    Jae Kyung Roh
    Hyun Cheol Chung
    Joong Bae Ahn
    Investigational New Drugs, 2012, 30 : 1501 - 1510
  • [3] Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer
    Emi, Manabu
    Yamaguchi, Yoshiyuki
    Hihara, Jun
    Hironaka, Katsuji
    Okada, Morihito
    ONCOLOGY LETTERS, 2010, 1 (01) : 95 - 98
  • [4] A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer
    Jeeyun Lee
    Sang Joon Shin
    Ik Joo Chung
    Tae Won Kim
    Hoo-Geun Chun
    Dong Bok Shin
    Yeul Hong Kim
    Hong Suk Song
    Sae-Won Han
    Jong Gwang Kim
    Sun Young Kim
    Young Jin Choi
    Hyun Cheol Chung
    Investigational New Drugs, 2014, 32 : 561 - 568
  • [5] A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer
    Shin, Sang Joon
    Lee, Jeeyun
    Chung, Ik-Joo
    Kim, Tae Won
    Chun, Hoo Geun
    Shin, Dongbok
    Kim, Yeul Hong
    Song, Hong-Suk
    Han, Sae-Won
    Kim, Jong Gwang
    Kim, Sun Young
    Choi, Young Jin
    Chung, Hyun Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [6] A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer
    Lee, Jeeyun
    Shin, Sang Joon
    Chung, Ik Joo
    Kim, Tae Won
    Chun, Hoo-Geun
    Shin, Dong Bok
    Kim, Yeul Hong
    Song, Hong Suk
    Han, Sae-Won
    Kim, Jong Gwang
    Kim, Sun Young
    Choi, Young Jin
    Chung, Hyun Cheol
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (03) : 561 - 568
  • [7] A phase Ib pharmacokinetic (PK) study of CKD-732 plus capecitabine and oxaliplatin (XELOX) in patients with metastatic colorectal cancer (mCRC) treated with prior irinotecan-based chemotherapy.
    Shin, S. J.
    Ahn, J.
    Park, K.
    Hong, Y.
    Kim, T.
    Jeung, H.
    Rha, S. Y.
    Roh, J. K.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    Koizumi, W.
    Yamaguchi, K.
    Hosaka, H.
    Takinishi, Y.
    Nakayama, N.
    Hara, T.
    Muro, K.
    Baba, H.
    Sasaki, Y.
    Nishina, T.
    Fuse, N.
    Esaki, T.
    Takagi, M.
    Gotoh, M.
    Sasaki, T.
    BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2079 - 2086
  • [9] Randomized phase II study of S-1/CDDP plus TSU-68 versus S-1/CDDP in patients with advanced gastric cancer
    Yamaguchi, Kensei
    Koizumi, Wasaburo
    Hosaka, Hisashi
    Takinishi, Yasutaka
    Nakayama, Norisuke
    Hara, Takuo
    Muro, Kei
    Baba, Hideo
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Fuse, Nozomu
    Esaki, Taito
    Takagi, Masakazu
    Gotoh, Masahiro
    Kitamura, Ryuichi
    Matsumoto, Hideki
    Sasaki, Tsuneo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [10] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    W Koizumi
    K Yamaguchi
    H Hosaka
    Y Takinishi
    N Nakayama
    T Hara
    K Muro
    H Baba
    Y Sasaki
    T Nishina
    N Fuse
    T Esaki
    M Takagi
    M Gotoh
    T Sasaki
    British Journal of Cancer, 2013, 109 : 2079 - 2086
12345